Ondine Biomedical Inc. (LON:OBI - Get Free Report) traded down 2.4% during trading on Wednesday . The company traded as low as C$10.00 and last traded at C$10.00. 6,261 shares were traded during mid-day trading, a decline of 98% from the average session volume of 313,582 shares. The stock had previously closed at C$10.25.
Ondine Biomedical Price Performance
The stock has a market cap of C$71.90 million, a price-to-earnings ratio of -3.01 and a beta of 0.10. The company has a debt-to-equity ratio of 25.95, a current ratio of 1.36 and a quick ratio of 8.26. The stock's 50 day simple moving average is C$11.26 and its two-hundred day simple moving average is C$8.98.
Insider Transactions at Ondine Biomedical
In related news, insider Carolyn Cross acquired 149,225 shares of the stock in a transaction dated Monday, February 3rd. The shares were bought at an average cost of C$13.00 per share, for a total transaction of C$1,939,925.00. 36.69% of the stock is owned by insiders.
About Ondine Biomedical
(
Get Free Report)
Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.
Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.
Featured Articles
Before you consider Ondine Biomedical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ondine Biomedical wasn't on the list.
While Ondine Biomedical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
